With Johnson & Johnson set to establish its third Asian JLAB site in South Korea and Merck KGaA planning its biggest APAC investment in a major bioprocessing center in the country, global big pharma firms now appear to be shifting more of their attention to the Northeast Asian nation.
Window Of Opportunity: Korea Unveils Cutting-Edge Bio Initiative
Presidential Pledges
South Korea is moving forward with plan to set up a Boston-type biotech cluster in Osong as part of a broader initiative unveiled by President Yoon, while the biopharma industry is calling for rapid process, exceptional support.
